Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RAC1P2 ("Rac family small GTPase 1 pseudogene 2") is annotated as a pseudogene in the human genome and does not encode a functional protein or receptor[5]. While its parent gene, RAC1, encodes a small GTPase involved in regulation of actin cytoskeleton and signaling pathways relevant to cell proliferation and migration, RAC1P2 itself is not known to have coding function, nor is it recognized as a therapeutic target[5]. Its nomenclature and available database entries confirm it is a genomic locus lacking protein-coding potential, and there is no evidence for direct involvement in disease processes, signal transduction, or drug interaction. Thus, for structured biomedical information or drug discovery purposes, RAC1P2 should not be considered a valid biological target. Note: If you intended to refer to Rac family small GTPase 1 (RAC1), which is a small GTPase and a well-established molecular target across cancer and other diseases[1][3][4], please clarify, as RAC1 and RAC1P2 are distinct entities — the former is a protein-coding therapeutic target, the latter is a pseudogene and not considered a functional molecular target[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rac family small GTPase 1 pseudogene 2 (RAC1P2).